(Q34462218)

2 August 2017

title

Bisphosphonates and risk of upper gastrointestinal cancer--a case control study using the General Practice Research Database (GPRD). (English)

1 reference

2 August 2017

0 references

Peter T Schofield

2

0 references

Paul Seed

object named as

Paul Seed

series ordinal

3

0 references

author name string

Ellen Wright

series ordinal

1

1 reference

2 August 2017

Mariam Molokhia

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

24 October 2012

1 reference

2 August 2017

1 reference

2 August 2017

volume

7

1 reference

2 August 2017

issue

10

1 reference

2 August 2017

page(s)

e47616

1 reference

Creative Commons Attribution 4.0 International

2 August 2017

copyright license

start time

24 October 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

An evaluation of the use of oral bisphosphonates and risk of esophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Exposure to bisphosphonates and risk of cancer: a protocol for nested case-control studies using the QResearch primary care database

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Identification of esophageal cancer in the General Practice Research Database

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Exposure to oral bisphosphonates and risk of esophageal cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Validity of diagnostic coding within the General Practice Research Database: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Validation and validity of diagnoses in the General Practice Research Database: a systematic review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Pathological effects of drugs on the gastrointestinal tract: a review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

A new probable increasing cause of esophageal ulceration: alendronate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Reports of esophageal cancer with oral bisphosphonate use.

6 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0047616

Oral bisphosphonates and risk of esophageal cancer: a dose-intensity analysis in a nationwide population

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0047616

Esophageal and gastric cancer incidence and mortality in alendronate users.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

More on reports of esophageal cancer with oral bisphosphonate use.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

14 day endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by Helicobacter pylori status

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480418

Bisphosphonates and esophageal cancer—a pathway through the confusion

27 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0047616

Oral bisphosphonate prescriptions and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus

21 January 2018

1 reference

12 December 2020

Alendronate and risk of esophageal cancer: a nationwide population-based study in Taiwan

1 reference

12 December 2020

Occurrence of gastrointestinal cancer in users of bisphosphonates and other antiresorptive drugs against osteoporosis

1 reference

12 December 2020

Oral bisphosphonates and oesophageal cancer

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0047616

Identifiers

DOI

1 reference

2 August 2017

0 references

1 reference

2 August 2017

1 reference